Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes - Takeaways - MDSpire

Impact of Roux-en-Y Gastric Bypass Limb Length on HbA1c Levels in Obese Individuals with Type 2 Diabetes

  • By

  • Lena Seidemann

  • Roland Morgenroth

  • Yusef Moulla

  • Undine Gabriele Lange

  • Orestis Lyros

  • Matthias Blüher

  • David Petroff

  • Christiane Prettin

  • Norbert Köhler

  • Arne Dietrich

  • April 21, 2026

  • 0 min

Share

  • 1

    The MetaSurg study assessed the impact of Roux-en-Y gastric bypass limb lengths on HbA1c levels in obese individuals with type 2 diabetes.

  • 2

    Participants included adults with a BMI of 27 to 60 kg/m2 and confirmed type 2 diabetes, with specific inclusion and exclusion criteria.

  • 3

    The study compared two surgical arms: long alimentary limb (AL) versus long biliopancreatic limb (BPL) RYGB procedures.

  • 4

    The primary endpoint was HbA1c levels at 12 months, with secondary endpoints including diabetes remission rates and various anthropometric measures.

  • 5

    The trial was conducted in accordance with ethical guidelines and aimed to provide insights into optimizing RYGB for diabetes management.

Original Source(s)

Related Content